Apoptotic effects of topical antiglaucoma medications on conjunctival epithelium in glaucoma patients

Mustafa Kemal Arici1, Dilek Sema Arici, Ayşe Vural Ozeç

  • 11 Department of Ophthalmology, Cumhuriyet University, School of Medicine, Sivas - Turkey.

Abstract

Insights

Topical antiglaucoma medications significantly increase apoptosis in conjunctival epithelial cells. However, the number, duration, or type of glaucoma medication did not influence this apoptotic effect.

Area of Science:

  • Ophthalmology
  • Cell Biology

Background:

  • Glaucoma is a leading cause of irreversible blindness worldwide.
  • Topical antiglaucoma medications are the primary treatment modality.
  • Conjunctival epithelium health is crucial for ocular surface homeostasis.

Purpose of the Study:

  • To investigate the apoptotic effects of topical antiglaucoma medications on conjunctival epithelial cells.
  • To determine if medication characteristics influence apoptosis rates.

Main Methods:

  • A comparative study involving 65 patients undergoing ocular surgery.
  • Patients were categorized into three groups: pre-trabeculectomy antiglaucoma medication users, non-users, and cataract surgery controls.
  • Conjunctival biopsies were analyzed for apoptosis using the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) method.

Main Results:

  • The mean apoptosis rate was significantly higher in patients using topical antiglaucoma medications compared to non-users and controls (p = 0.0001).
  • No significant correlation was found between the number of medications, duration of use, or glaucoma type and the observed apoptosis rates.

Conclusions:

  • Topical antiglaucoma drugs induce apoptosis in conjunctival epithelial cells.
  • The extent of apoptosis is not influenced by the number, duration, or type of glaucoma medication used.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...